| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ac48f029871a88e33d5ab3b0436aa84 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616 |
| filingDate |
2015-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0c378297b2569ca17a0660a52a71c65 |
| publicationDate |
2016-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-106102748-A |
| titleOfInvention |
dry powder formulation for inhalation |
| abstract |
The present application relates to an inhalable dry powder comprising acetylsalicylic acid in particulate form having a mass median aerodynamic diameter (MMAD) in the range of about 0.5 μm to about 10 μm. The inhalable dry powder may contain a pharmaceutically acceptable excipient, such as a phospholipid, in an amount ranging from about 0.1% (w/w) to about 10% (w/w) of the particle. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108148102-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111315363-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111315363-B |
| priorityDate |
2014-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |